TBI: To Be (Irradiated) or Not To Be? That Remains the Question.

作者信息

Hamilton Betty Ky

机构信息

Blood and Marrow Transplant Program, Department of Hematologic Oncology and Blood Disorders, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio.

出版信息

Biol Blood Marrow Transplant. 2018 Aug;24(8):1535-1536. doi: 10.1016/j.bbmt.2018.06.008. Epub 2018 Jun 14.

DOI:10.1016/j.bbmt.2018.06.008

PMID:29909150

Abstract

摘要

相似文献

TBI: To Be (Irradiated) or Not To Be? That Remains the Question.

Biol Blood Marrow Transplant. 2018 Aug;24(8):1535-1536. doi: 10.1016/j.bbmt.2018.06.008. Epub 2018 Jun 14.

Pulmonary complications of bone marrow transplantation: a comparison of total body irradiation and cyclophosphamide to busulfan and cyclophosphamide.骨髓移植的肺部并发症：全身照射与环磷酰胺联合白消安与环磷酰胺的比较

Int J Radiat Oncol Biol Phys. 1995 Apr 30;32(1):69-73. doi: 10.1016/0360-3016(94)00541-R.

Outcomes after use of two standard ablative regimens in patients with refractory acute myeloid leukaemia: a retrospective, multicentre, registry analysis.难治性急性髓系白血病患者使用两种标准消融方案后的结局：一项回顾性、多中心、注册研究分析。

Lancet Haematol. 2015 Sep;2(9):e384-92. doi: 10.1016/S2352-3026(15)00146-5. Epub 2015 Aug 24.

Long-term outcomes of total body irradiation plus cyclophosphamide versus busulfan plus cyclophosphamide as conditioning regimen for acute lymphoblastic leukemia: a comparative study.全身照射联合环磷酰胺与白消安联合环磷酰胺作为急性淋巴细胞白血病预处理方案的长期疗效比较：一项对照研究。

Ann Hematol. 2018 Oct;97(10):1987-1994. doi: 10.1007/s00277-018-3383-9. Epub 2018 Jun 5.

[Mini-transplantation from cord blood].

Nihon Rinsho. 2003 Sep;61(9):1555-60.

Comparison of Cyclophosphamide Combined with Total Body Irradiation, Oral Busulfan, or Intravenous Busulfan for Allogeneic Hematopoietic Cell Transplantation in Adults with Acute Lymphoblastic Leukemia.环磷酰胺联合全身照射、口服白消安或静脉注射白消安用于成人急性淋巴细胞白血病异基因造血细胞移植的比较

Biol Blood Marrow Transplant. 2016 Dec;22(12):2194-2200. doi: 10.1016/j.bbmt.2016.09.007. Epub 2016 Sep 13.

Escalating doses of etoposide with cyclophosphamide and fractionated total body irradiation or busulfan as conditioning for bone marrow transplantation.递增剂量的依托泊苷联合环磷酰胺以及分次全身照射或白消安作为骨髓移植的预处理。

Bone Marrow Transplant. 1989 Sep;4(5):559-65.

High busulfan exposure is associated with worse outcomes in a daily i.v. busulfan and fludarabine allogeneic transplant regimen.在每日静脉注射白消安和氟达拉滨的异基因移植方案中，高剂量白消安暴露与更差的预后相关。

Biol Blood Marrow Transplant. 2008 Feb;14(2):220-8. doi: 10.1016/j.bbmt.2007.10.028.

Fludarabine and exposure-targeted busulfan compares favorably with busulfan/cyclophosphamide-based regimens in pediatric hematopoietic cell transplantation: maintaining efficacy with less toxicity.氟达拉滨和暴露靶向的白消安与基于白消安/环磷酰胺的方案相比在儿科造血细胞移植中具有优势：以更少的毒性维持疗效。

Biol Blood Marrow Transplant. 2014 Mar;20(3):345-53. doi: 10.1016/j.bbmt.2013.11.027. Epub 2013 Dec 4.

Reduced intensity conditioning regimen with fludarabine, busulfan, and low-dose TBI (Flu-BU2-TBI): clinical efficacy in high-risk patients.氟达拉滨、白消安和低剂量 TBI（Flu-BU2-TBI）的降低强度预处理方案：高危患者的临床疗效。

Am J Hematol. 2010 Apr;85(4):243-8. doi: 10.1002/ajh.21630.

引用本文的文献

Twenty years of experience of a tertiary cancer center in total body irradiation with focus on oncological outcome and secondary malignancies.20 年的全身放疗经验，重点关注肿瘤学结果和继发性恶性肿瘤。

Strahlenther Onkol. 2022 Jun;198(6):547-557. doi: 10.1007/s00066-022-01914-5. Epub 2022 Mar 22.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验